Gene therapy for neovascular age-related macular degeneration is linked to positive anatomical changes, but variable visual outcomes.

Purpose The cross-sectional and longitudinal associations between accelerated biological ageing and the risk of cataract and ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

Researchers developed and validated a machine-learning model to differentiate uveitic and diabetic macular edema using ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

The former macular support group for Caithness has been given a new name after being taken under the wing of local charity Hearing and Sight Care.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye, and it marks the first of a three-part series on dry ...

New treatments for dry macular degeneration are helping slow vision loss, and researchers are testing therapies that may restore sight. Here’s what to know. Dry age-related macular degeneration is the ...

ORLANDO, Fla. (Ivanhoe Newswire) - There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it happens when small deposits form under ...

There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it happens when small deposits form under the retina, causing cells in the ...

A large retinal imaging study suggests a common diabetes drug may help slow progression toward sight-threatening macular degeneration, though clinical trials are still needed to confirm any protective ...